Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2697 |
|
Actual shortage: | 241 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2447 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-CLOBETASOL | 0.05% | LOTION | Resolved | 2017-03-10 | 2017-11-07 | 167 |
TEVA-CLOBETASOL | 0.05% | LOTION | Resolved | 2017-03-14 | 2017-11-06 | 2370 |
TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2017-09-21 | 2017-11-06 | 22942 |
RATIO-DOCUSATE SODIUM | 20MG | SYRUP | Resolved | 2020-03-12 | 2020-04-23 | 108604 |
RATIO-DOCUSATE SODIUM | 20MG | SYRUP | Resolved | 2020-11-12 | 2021-01-21 | 128327 |
RATIO-DOCUSATE SODIUM | 20MG | SYRUP | Resolved | 2023-07-04 | 2024-02-07 | 197195 |
TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2017-03-14 | 2018-02-21 | 2374 |
TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2017-03-14 | 2018-03-08 | 2380 |
TEVA-ECTOSONE | 0.05% | LOTION | Resolved | 2017-09-21 | 2018-03-07 | 22945 |
TEVA-ECTOSONE | 0.1% | CREAM | Resolved | 2018-03-13 | 2018-10-11 | 42622 |
TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2017-08-14 | 2018-01-03 | 19304 |
RATIO-IPRA SAL UDV | 0.5MG 2.5MG | SOLUTION | Resolved | 2017-03-17 | 2017-07-28 | 3137 |
RATIO-IPRA SAL UDV | 0.5MG 2.5MG | SOLUTION | Resolved | 2019-07-02 | 2019-07-16 | 88167 |
RATIO-IPRATROPIUM UDV | 250MCG | SOLUTION | Resolved | 2017-05-23 | 2017-09-19 | 10892 |
TEVA-IRBESARTAN | 150MG | TABLET | Resolved | 2017-08-14 | 2017-09-19 | 19308 |
TEVA-IRBESARTAN HCTZ | 12.5MG 300MG | TABLET | Resolved | 2017-05-10 | 2017-09-19 | 9785 |
TEVA-IRBESARTAN HCTZ | 25MG 300MG | TABLET | Resolved | 2017-08-01 | 2017-09-19 | 17839 |
TEVA-IRBESARTAN HCTZ | 12.5MG 300MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42582 |
RATIO-LACTULOSE | 667MG/ML | BOTTLE | Resolved | 2017-03-14 | 2017-12-15 | 2400 |
RATIO-LACTULOSE | 667MG | SOLUTION | Actual shortage | 2024-05-03 | 2024-05-03 | 226933 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-10-25 | 2019-10-26 | 97251 |
NOVAMOXIN | 250MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104289 |
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
NOVO-PROFEN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64920 |
NOVO-PROFEN | 200MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81310 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-12 | 2018-10-12 | 63943 |
RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-19 | 2018-10-19 | 64891 |
TEVA-LENOLTEC NO. 1 | 300MG 8MG 15MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81362 |
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 |